Benzquinamide
{{Short description|Chemical compound}}
{{redirect|Quantril|the surname|Quantrill}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459955149
| IUPAC_name = 3-(Diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate
| image = Benzquinamide.svg
| image_class = skin-invert-image
| width =
| alt =
| image2 =
| width2 =
| drug_name =
| tradename = Promecon, Quantril, Emete-Con
| licence_EU =
| licence_US = Quantril
| DailyMedID =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_BR = C1
| legal_BR_comment = {{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=Diário Oficial da União |language=pt-BR |publication-date=2023-04-04}}
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| dependency_liability =
| routes_of_administration = Suppository, injection
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 63-12-7
| CAS_supplemental =
| ATCvet =
| ATC_prefix = none
| ATC_suffix =
| ATC_supplemental =
| PubChem =
| PubChemSubstance =
| IUPHAR_ligand = 7124
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00767
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 2252
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0475EA27Q3
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D00243
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201250
| synonyms =
| C=22 | H=32 | N=2 | O=5
| SMILES = CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(=O)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = InChI=1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = JSZILQVIPPROJI-UHFFFAOYSA-N
| density =
| melting_point =
| melting_high =
| melting_notes =
| boiling_point =
| boiling_notes =
| solubility =
| specific_rotation =
| sec_combustion =
}}
Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.{{cite journal|vauthors = Scriabine A, Weissman A, Finger KF|title=Benzquinamide|journal=JAMA|volume=184|issue=4|year=1963|pages=276–279|issn=0098-7484|doi=10.1001/jama.1963.73700170001010|pmid=13992595}}
References
{{reflist}}
{{gastrointestinal-drug-stub}}